MIM Solutions and the Swedish start-up AcoraiAB are starting a project aimed at better predicting the prognosis of cardiac patients. As part of the project, MIM Solutions will be responsible for the development of software for analyzing data from medical records and data from an innovative non-invasive device created by the consortium leader. The project will support the transfer of our tools for the analysis of medical documents and records to international markets. The project is co-financed by the international EUROSTARS within the EUREKA network.
News
MedTech News: November 2022
Multiple FDA clearances for AI-powered products! The United States Food and Drug Administration is an agency which certifies medical products in the United